Tokyo

Running trials

• Recruiting

  A Survey of Susoctocog Alfa (Genetical Recombination) in Participants With Acquired Haemophilia A

  NCT06461533· Source

• Recruiting

  A Survey of Brentuximab Vedotin in Pediatric Participants With Hodgkin Lymphoma

  NCT05481437· Source

• Recruiting

  A Survey of Darvadstrocel in People With Crohn's Disease

  NCT05113095· Source

• Recruiting

  Survey of Brigatinib Used To Treat People With Non-Small Cell Lung Cancer

  NCT05100069· Source

• Active, not recruiting

  An Additional Analysis of Data From the PARADIGM Exploratory Study (NCT02394834) in Patients With Advanced/Recurrent Colorectal Cancer

  NCT05030493· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Childhood cancers2 recruiting
• Crohn's disease1 recruiting
• Haemophilia1 recruiting
• Hodgkin lymphoma1 recruiting
• Lung cancer1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  A Database Survey of Comparison The Risk of Haemorrhage Between Vortioxetine Tablet Treatment and Selective Serotonin Reuptake Inhibitor (SSRI) Treatment in Participants With Depression

  NCT05932407· Source

• Completed

  A Study of Azilsartan in Children From 6 to Less Than 16 Years Old With High Blood Pressure

  NCT05107960· Source

• Completed

  Survey of Cabozantinib Tablets Used To Treat People With Hepatocellular Carcinoma

  NCT05100082· Source

• Completed

  A Study of Niraparib in Patients With Ovarian Cancer in Clinical Practice

  NCT05021562· Source

• Completed

  A Study of TAK-660 in Surgical Procedures for People With Hemophilia A.

  NCT04941898· Source

• Completed

  Survey of Cabozantinib Used To Treat People With Renal Cell Carcinoma

  NCT04804813· Source

• Completed

  Special Drug Use Surveillance for Brentuximab Vedotin Intravenous Infusion "Relapsed or Refractory CD30-positive Peripheral T Cell Lymphoma or Pediatric Hodgkin Lymphoma"

  NCT04213209· Source

• Completed

  Specified Drug-Use Survey on Vedolizumab for IV Infusion 300 mg [Crohn's Disease]

  NCT04002180· Source

• Completed

  Special Drug-Use Surveillance Study on Vedolizumab for IV Infusion 300 mg [Ulcerative Colitis]

  NCT03824561· Source

• Completed

  Specified Drug-Use Survey of Leuprorelin Acetate Injection Kit 11.25 mg "All-Case Investigation: Spinal and Bulbar Muscular Atrophy (SBMA)"

  NCT03555578· Source

• Completed

  Copaxone Subcutaneous Injection Syringe Special Drug Use-Result Investigation (All-Case Investigation) "Prevention of Relapse of Multiple Sclerosis"

  NCT03209479· Source